Med. praxi. 2025;22(1):16-19 | DOI: 10.36290/med.2025.001

New psychoactive substances in the Czech environment

Mgr. Tomáš Jandáč, Ph.D.
Klinika adiktologie, Univerzita Karlova, 1. lékařská fakulta, Praha
Klinika adiktologie, Všeobecná fakultní nemocnice v Praze

The main objective of this text is to introduce new psychoactive substances, which encompass a broad and diverse group of substances, mostly of synthetic origin, with primarily stimulating, sedative, and hallucinogenic effects. These substances were developed or reintroduced to the market to replace traditional addictive substances, and their production often aims to circumvent legislation. The text discusses various subgroups of these substances, such as synthetic cannabinoids and opioids, and their serious health risks, including neurotoxic and cardiovascular complications. It also focuses on specific user groups who prefer these substances and their reasons for use, including attempts to avoid drug detection or enhance sexual experiences. Special attention is also given to new psychedelic substances and kratom, including their pharmacological properties and health risks. The article emphasizes the complexity of the phenomenon of new psychoactive substances and the need for increased attention from healthcare professionals in identifying and treating intoxications with these substances.

Keywords: addiction medicine, new psychoactive substances, specific target groups.

Received: August 30, 2024; Revised: November 1, 2024; Accepted: January 20, 2025; Published: February 20, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jandáč T. New psychoactive substances in the Czech environment. Med. praxi. 2025;22(1):16-19. doi: 10.36290/med.2025.001.
Download citation

References

  1. Santos GM, Hernandez C, Lam E, et al. Racial/Ethnic Disparities in Club Drug Use, Situational Club Drug Use during Sex, and Sexual Risk Behaviors among Alcohol­‑Using Men Who Have Sex with Men (MSM) in San Francisco. Subst Use Misuse. 2024;59(6):895-901. doi: 10.1080/10826084.2024.2310480. Epub 2024 Feb 2. PMID: 38307836; PMCID: PMC11131949. Go to original source... Go to PubMed...
  2. Chomynová P, Dvořáková Z, Grohmannová K, et al. Souhrnná zprávu o závislostech v České republice 2022. Praha: Úřad vlády; 2023.
  3. Independent Expert Working Group. Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health; 2017.
  4. Le Boisselier R, Alexandre J, Lelong­‑Boulouard V, et al. Focus on cannabinoids and synthetic cannabinoids. Clin Pharmacol Ther. 2017;101(2):220-9. Go to original source... Go to PubMed...
  5. Lauritsen KJ, Rosenberg H, Sprague JE. University students' attributions for abstinence from synthetic cannabinoids and synthetic cathinones. Am J Drug Alcohol Abuse. 2018 Jan 2;44(1):64-72. Go to original source... Go to PubMed...
  6. Cruz SL. Opioids: pharmacology, abuse, and addiction. Cham, Switzerland: Springer; 2022. Go to original source...
  7. Shafi A, Berry AJ, Sumnall H, et al. Synthetic opioids: a review and clinical update. Ther Adv Psychopharmacol. 2022 Jan 1;12:20451253221139616. Go to original source... Go to PubMed...
  8. Coppola M, Mondola R. AH-7921: A new synthetic opioid of abuse. Drug Alcohol Rev. 2015;34(1):109-10. Go to original source... Go to PubMed...
  9. European Monitoring Centre for Drugs and Drug Addiction. European drug report 2024 [Internet]. LU: Publications Office; 2024 [cited 2024 Aug 28]. Available from: https://data.europa.eu/doi/10.2810/91693.
  10. Varì MR, Pichini S, Giorgetti R, et al. New psychoactive substances - Synthetic stimulants. WIREs Forensic Sci. 2019;1(2):e1197. Go to original source...
  11. Soares J, Costa VM, Bastos M de L, et al. An updated review on synthetic cathinones. Arch Toxicol. 2021 Sep 1;95(9):2895-940. Go to original source... Go to PubMed...
  12. Hase A, Erdmann M, Limbach V, et al. Analysis of recreational psychedelic substance use experiences classified by substance. Psychopharmacology (Berl). 2022 Feb 1;239(2):643-59. Go to original source... Go to PubMed...
  13. Bischoff K. Chapter 22 - Toxicity of Drugs of Abuse. In: Veterinary Toxicology. Third Edition. Elsevier Inc; 2018. p. 385-408. Go to original source...
  14. Mallaroni P, Mason NL, Reckweg JT, et al. Assessment of the Acute Effects of 2C­‑B vs. Psilocybin on Subjective Experience, Mood, and Cognition. Clin Pharmacol Ther. 2023;114(2):423-33. Go to original source... Go to PubMed...
  15. Papaseit E, Farré M, Pérez­‑Mañá C, et al. Acute Pharmacological Effects of 2C­‑B in Humans: An Observational Study. Front Pharmacol [Internet]. 2018 Mar 13 [cited 2024 Aug 28];9. Available from: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2018.00206/full. Go to original source... Go to PubMed...
  16. Sharma R, Barnes J. Kratom. J Prim Health Care. 2022 Sep 20;14(3):288-90. Go to original source... Go to PubMed...
  17. Veltri C, Grundmann O. Current perspectives on the impact of Kratom use. Subst Abuse Rehabil. 2019 Jul 1;10:23-31. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.